Titan Pharmaceuticals (TTNP) Competitors $4.34 -0.02 (-0.34%) Closing price 05/21/2025 03:50 PM EasternExtended Trading$4.34 +0.00 (+0.12%) As of 05/21/2025 06:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TTNP vs. ALLR, GOVX, TRIB, COCP, RLYB, ERNA, ABP, EDSA, MBRX, and UBXShould you be buying Titan Pharmaceuticals stock or one of its competitors? The main competitors of Titan Pharmaceuticals include Allarity Therapeutics (ALLR), GeoVax Labs (GOVX), Trinity Biotech (TRIB), Cocrystal Pharma (COCP), Rallybio (RLYB), Eterna Therapeutics (ERNA), Abpro (ABP), Edesa Biotech (EDSA), Moleculin Biotech (MBRX), and Unity Biotechnology (UBX). These companies are all part of the "pharmaceutical products" industry. Titan Pharmaceuticals vs. Allarity Therapeutics GeoVax Labs Trinity Biotech Cocrystal Pharma Rallybio Eterna Therapeutics Abpro Edesa Biotech Moleculin Biotech Unity Biotechnology Titan Pharmaceuticals (NASDAQ:TTNP) and Allarity Therapeutics (NASDAQ:ALLR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability. Which has more volatility & risk, TTNP or ALLR? Titan Pharmaceuticals has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500. Comparatively, Allarity Therapeutics has a beta of -0.14, meaning that its share price is 114% less volatile than the S&P 500. Does the media refer more to TTNP or ALLR? In the previous week, Titan Pharmaceuticals' average media sentiment score of 1.38 beat Allarity Therapeutics' score of 0.00 indicating that Titan Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Titan Pharmaceuticals Positive Allarity Therapeutics Neutral Which has preferable earnings and valuation, TTNP or ALLR? Titan Pharmaceuticals has higher revenue and earnings than Allarity Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTitan Pharmaceuticals$180K22.01-$5.57M-$4.59-0.94Allarity TherapeuticsN/AN/A-$11.90MN/AN/A Is TTNP or ALLR more profitable? Titan Pharmaceuticals' return on equity of -118.01% beat Allarity Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Titan PharmaceuticalsN/A -118.01% -103.79% Allarity Therapeutics N/A -369.67%-100.06% Do insiders & institutionals have more ownership in TTNP or ALLR? 31.5% of Titan Pharmaceuticals shares are owned by institutional investors. Comparatively, 11.5% of Allarity Therapeutics shares are owned by institutional investors. 0.7% of Titan Pharmaceuticals shares are owned by insiders. Comparatively, 0.0% of Allarity Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community favor TTNP or ALLR? Titan Pharmaceuticals received 334 more outperform votes than Allarity Therapeutics when rated by MarketBeat users. Likewise, 52.84% of users gave Titan Pharmaceuticals an outperform vote while only 50.00% of users gave Allarity Therapeutics an outperform vote. CompanyUnderperformOutperformTitan PharmaceuticalsOutperform Votes33552.84% Underperform Votes29947.16% Allarity TherapeuticsOutperform Votes150.00% Underperform Votes150.00% SummaryTitan Pharmaceuticals beats Allarity Therapeutics on 9 of the 10 factors compared between the two stocks. Get Titan Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TTNP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTNP vs. The Competition Export to ExcelMetricTitan PharmaceuticalsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.98M$2.93B$5.38B$8.39BDividend YieldN/A1.71%5.21%4.10%P/E Ratio-0.9430.5026.8019.71Price / Sales22.01400.15389.55117.28Price / CashN/A168.6838.2534.62Price / Book0.493.286.804.50Net Income-$5.57M-$72.17M$3.23B$248.18M7 Day Performance-10.80%2.96%1.53%0.23%1 Month Performance21.09%3.25%10.05%12.39%1 Year Performance-34.71%-28.29%16.75%7.07% Titan Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTNPTitan Pharmaceuticals0.6002 of 5 stars$4.34-0.3%N/A-31.7%$3.98M$180,000.00-0.9410Analyst ForecastGap UpALLRAllarity Therapeutics0.1318 of 5 stars$1.07+2.9%N/A-93.8%$16.14MN/A0.0010GOVXGeoVax Labs2.1579 of 5 stars$1.02+3.6%$11.10+988.2%-39.1%$15.50M$5.59M-0.2810TRIBTrinity Biotech0.7139 of 5 stars$0.82-3.2%N/A-49.9%$14.80M$59.13M-0.36480Gap DownCOCPCocrystal Pharma3.1462 of 5 stars$1.41-0.7%$7.00+396.5%-24.7%$14.44MN/A-0.7610Earnings ReportAnalyst RevisionRLYBRallybio1.8773 of 5 stars$0.35-0.9%$10.00+2,781.8%-79.8%$14.44M$848,000.00-0.2240Gap DownERNAEterna Therapeutics0.7596 of 5 stars$0.23+2.7%N/A-88.9%$14.34M$582,000.00-0.0310ABPAbproN/A$0.27+18.3%$4.00+1,370.6%N/A$14.20M$183,000.000.0015Earnings ReportGap DownHigh Trading VolumeEDSAEdesa Biotech2.8432 of 5 stars$2.01-1.0%$21.00+944.8%-55.7%$14.12MN/A-1.0720Gap DownMBRXMoleculin Biotech1.9585 of 5 stars$0.99+5.7%$6.00+503.9%-80.4%$14.04MN/A0.0020UBXUnity Biotechnology3.6596 of 5 stars$0.81-1.3%$4.25+425.3%-49.5%$13.93M$240,000.00-0.6260 Related Companies and Tools Related Companies Allarity Therapeutics Alternatives GeoVax Labs Alternatives Trinity Biotech Alternatives Cocrystal Pharma Alternatives Rallybio Alternatives Eterna Therapeutics Alternatives Abpro Alternatives Edesa Biotech Alternatives Moleculin Biotech Alternatives Unity Biotechnology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TTNP) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
